Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section

• Status: Completed
• Trial end date: 2020-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Our aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine 0.25% alone in transversus abdominis plane (TAP) block for postoperative analgesia in patients undergoing an elective Caesarean section.

• Group 1: bupivacaine 0.25% + dexamethasone 8 mg

• Group 2: bupivacaine 0.25% A prospective Randomized Interventional double-blind study.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: BB 1101; Bupivacaine; Dexamethasone; Dexamethasone acetate

Criteria

Inclusion Criteria:

• healthy parturient (ASA I and II) scheduled to undergo LSCS under spinal anesthesia

Exclusion Criteria:

• Participants had known sensitivity to bupivacaine

• patient refusal,

• localized infection over injection point

• patients with significant coagulopathies and

• with contraindications to regional anesthesia,

• patients with heart diseases, altered renal or liver functions,

• psychological disorders, patients with pregnancy-induced hypertension and

• gestational diabetes, chronic use of pain medications,